Timely and accurate diagnostics such as rapid tests are essential to tackle AMR. In many countries, tests used to identify bacterial infections are carried out in laboratories and typically take 2-3 days to produce an accurate test result.
Oxford scientists are developing rapid diagnostic tests that will enable health professionals to administer the right drug at the right time and only when needed.
Current projects
Antimicrobial Resistance Testing
This Oxford Martin Programme aims to develop rapid tests that can both identify bacterial species and establish which antibiotics they are susceptible to, in as little as 30 minutes
DiAlS study
The Digital Alerting for Sepsis study (DiAIS) will investigate the impact of digital sepsis alerts on patient outcomes and staff activity in NHS hospital Trusts across England and Wales.
John Fell Study
The John Fell fund study aims to improve direct-from-sample diagnostic workflows for bacterial infections using nanopore sequencing, encompassing both rapid pathogen identification and prediction of antibiotic susceptibility phenotypes from genotype.
PRUDENCE trial
The study aims to discover if more appropriate prescribing decisions are made by health care professionals when a diagnostic test result is available for community-acquired acute respiratory tract.
TOUCAN study
The TOUCAN study evaluates new rapid tests for diagnosing urinary tract infections (UTIs) in GP practice.
Value-Dx study
This study aims to record information about patients who receive treatment for community acquired acute respiratory tract infection e.g. cough, sore throat. This will help researchers benchmark patterns of antibiotic prescribing in contrasting European settings by observing what happens in routine care